Protocol Ledger

Academic / Cooperative Group · Consolidated Sponsor Hub

University of Pennsylvania: Clinical Trials & FDA Approval Profile

University of Pennsylvania (Philadelphia, PA) sponsors 125 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 73 active protocols (49 recruiting now), 32 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)16.0%
Median Closed Enrollment vs National (145 pts)28 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for University of Pennsylvania
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)125
Active Pipeline (Recruiting Now)73 (49)
Completed vs Stopped Early32 / 20 (16.0%)
Median Closed Actual Enrollment28 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With University of Pennsylvania
Hospital Research SiteLocationShared Protocols
University of Pennsylvania Abramson Cancer CenterPhiladelphia, PA99
Vanderbilt University Medical CenterNashville, TN4
Huntsman Cancer Institute at University of UtahSalt Lake City, UT3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by University of Pennsylvania
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT04474847Abatacept for the Treatment of Giant Cell ArteritisPhase IIIRECRUITING

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Penn Medicine (University of Pennsylvania) across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the University of Pennsylvania Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI